D.E. Shaw & Co
XLRN

D.E. Shaw & Co’s Acceleron Pharma XLRN Stock Holding History

D.E. Shaw & Co’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,000
Closed -$743K – 3961
2018
Q1 		$743K Buy
+19,000
New +$808K ﹤0.01% 2686

D.E. Shaw & Co's XLRN Position: Q4 2021 in Review

D.E. Shaw & Co sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 271,291 shares — an estimated $46.7M sold.

D.E. Shaw & Co first reported a position in XLRN in Q1 2014 and held it in 17 quarters. The position peaked at $46.7M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • D.E. Shaw & Co reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 271,291 Acceleron Pharma shares in Q4 2021, an estimated $46.7M.
  • D.E. Shaw & Co first reported a position in Acceleron Pharma in Q1 2014 and held it in 17 quarters.
  • D.E. Shaw & Co's Acceleron Pharma position peaked at $46.7M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.